AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 61 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,805,732 | +373.3% | 254,564 | +160.6% | 0.00% | – |
| Q3 2022 | $804,000 | +26.2% | 97,689 | +0.6% | 0.00% | – |
| Q2 2022 | $637,000 | +17.3% | 97,089 | 0.0% | 0.00% | – |
| Q1 2022 | $543,000 | +30.2% | 97,089 | +9.2% | 0.00% | – |
| Q4 2021 | $417,000 | -24.0% | 88,895 | 0.0% | 0.00% | – |
| Q3 2021 | $549,000 | -13.3% | 88,895 | -7.4% | 0.00% | – |
| Q2 2021 | $633,000 | -72.6% | 95,995 | -69.5% | 0.00% | – |
| Q1 2021 | $2,307,000 | +43.6% | 315,187 | +13.3% | 0.00% | – |
| Q4 2020 | $1,606,000 | +41.6% | 278,267 | +45.7% | 0.00% | – |
| Q3 2020 | $1,134,000 | +67.5% | 190,934 | +45.2% | 0.00% | – |
| Q2 2020 | $677,000 | – | 131,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
| Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
| Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
| J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
| NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
| Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |